Literature DB >> 17210590

Epoetin trials: randomised controlled trials don't always mimic observational data.

Simon D Roger, Adeera Levin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17210590     DOI： 10.1093/ndt/gfl740

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  3 in total

1.  Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients.

Authors:  Hideki Hirakata; Yoshiharu Tsubakihara; Fumitake Gejyo; Shinichi Nishi; Yasuhiko Iino; Yuzou Watanabe; Masashi Suzuki; Akira Saito; Takashi Akiba; Daijo Inaguma; Shunichi Fukuhara; Satoshi Morita; Michiaki Hiroe; Yoshiyuki Hada; Makoto Suzuki; Makoto Akaishi; Kazutaka Aonuma; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2009-09-09       Impact factor: 2.801

2.  An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study.

Authors:  Jan-Christoph Galle; Kathleen Claes; Istvan Kiss; Christopher G Winearls; Hans Herlitz; Alain Guerin; Salvatore Di Giulio; Michael G Suranyi; Ian Bridges; Janet Addison; Mourad Farouk
Journal:  Nephrol Dial Transplant       Date:  2011-12-02       Impact factor: 5.992

3.  Individualizing anaemia therapy.

Authors:  Angel L M de Francisco
Journal:  NDT Plus       Date:  2010-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.